(Q28304399)

Ann-Marie Baker

1

0 references

Jon R Wilson

Jon R Wilson

8

0 references

Thomas R Cox

Thomas R Cox

2

0 references

Demelza Bird

3

Demelza Bird

0 references

Georgina Lang

4

Georgina Lang

0 references

author name string

Graeme I Murray

5

0 references

Xiao-Feng Sun

6

0 references

Stacey M Southall

Journal of the National Cancer Institute

7

0 references

language of work or name

English

0 references

publication date

2 March 2011

0 references

published in

0 references

volume

103

0 references

issue

5

0 references

page(s)

407-24

0 references

cites work

The staging of colorectal cancer: 2004 and beyond

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Metastasis: from dissemination to organ-specific colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Tumor metastasis: mechanistic insights and clinical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Three-dimensional context regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Cancer and the chemokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Paradoxical roles for lysyl oxidases in cancer--a prospect

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Properties and Function of Lysyl Oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Matrix crosslinking forces tumor progression by enhancing integrin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Lysyl oxidase mediates hypoxic control of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

A stiff blow from the stroma: collagen crosslinking drives tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Somatic mutations of the lysyl oxidase gene on chromosome 5q23.1 in colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Combination treatment of Cetuximab and photodynamic therapy in SNU-1041 squamous cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Can exercise ameliorate the increased risk of cardiovascular disease and diabetes associated with ADT?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Src family kinases in tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Latent bone metastasis in breast cancer tied to Src-dependent survival signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Characterisation and protein expression profiling of annexins in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Altered growth of human colon cancer cell lines disrupted at activated Ki-ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

NCM460, a normal human colon mucosal epithelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Discovery of a new class of anilinoquinazoline inhibitors with high affinity and specificity for the tyrosine kinase domain of c-Src

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Trihydroxyphenylalanine quinone (TPQ) from copper amine oxidases and lysyl tyrosylquinone (LTQ) from lysyl oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Modulation of lysyl oxidase-like 2 enzymatic activity by an allosteric antibody inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

DOCK10-mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Integrin signalling during tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Mechanical force modulates global gene expression and beta-catenin signaling in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Tensional homeostasis and the malignant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Signal transduction by focal adhesion kinase in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

Evaluation of metastatic and angiogenic potentials of human colon carcinoma cells in chick embryo model systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ569

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJQ569

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

21282564

1 reference

Consolidated OpenCitations Corpus – April 2017